0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nocturia Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-15D6207
Home | Market Reports | Health| Pharmacy
Global Nocturia Market Insights and Forecast to 2028
BUY CHAPTERS

Global Nocturia Market Research Report 2023

Code: QYRE-Auto-15D6207
Report
January 2023
Pages:89
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nocturia Market Size

The global Nocturia market was valued at US$ 2285.1 million in 2022 and is anticipated to reach US$ 3423.5 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029.

Nocturia Market

Nocturia Market

Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nocturia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nocturia.
The Nocturia market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nocturia market comprehensively. Regional market sizes, concerning products by type, by sale channels, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nocturia companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by sale channels, and by regions.

Scope of Nocturia Market Report

Report Metric Details
Report Name Nocturia Market
Accounted market size in 2022 US$ 2285.1 million
Forecasted market size in 2029 US$ 3423.5 million
CAGR 7.0%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Desmopressin
  • Anticholinergic Drugs
  • Alpha Blockers
  • Diuretics
  • Others
Segment by Sale Channels
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly, GlaxoSmithKline, Sanofi, Pfizer, Abbott, Teva, Mylan, Johnson & Johnson, Hainan Zhonghe Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, sale channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nocturia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by sale channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nocturia Market growing?

Ans: The Nocturia Market witnessing a CAGR of 7.0% during the forecast period 2023-2029.

What is the Nocturia Market size in 2029?

Ans: The global Nocturia market was valued at US$ 2285.1 million in 2022 and is anticipated to reach US$ 3423.5 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029.

What is the market share of major companies in Nocturia Market?

Ans: The top 2 companies hold a share about 30%.

What is the Nocturia Market share by region?

Ans: North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%.

What is the Nocturia Market share by type?

Ans: In terms of product, alpha blockers is the largest segment, with a share over 37%.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Desmopressin
1.2.3 Anticholinergic Drugs
1.2.4 Alpha Blockers
1.2.5 Diuretics
1.2.6 Others
1.3 Market by Sale Channels
1.3.1 Global Nocturia Market Growth by Sale Channels: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nocturia Market Perspective (2018-2029)
2.2 Nocturia Growth Trends by Region
2.2.1 Global Nocturia Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Nocturia Historic Market Size by Region (2018-2023)
2.2.3 Nocturia Forecasted Market Size by Region (2024-2029)
2.3 Nocturia Market Dynamics
2.3.1 Nocturia Industry Trends
2.3.2 Nocturia Market Drivers
2.3.3 Nocturia Market Challenges
2.3.4 Nocturia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturia Players by Revenue
3.1.1 Global Top Nocturia Players by Revenue (2018-2023)
3.1.2 Global Nocturia Revenue Market Share by Players (2018-2023)
3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nocturia Revenue
3.4 Global Nocturia Market Concentration Ratio
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2022
3.5 Nocturia Key Players Head office and Area Served
3.6 Key Players Nocturia Product Solution and Service
3.7 Date of Enter into Nocturia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturia Breakdown Data by Type
4.1 Global Nocturia Historic Market Size by Type (2018-2023)
4.2 Global Nocturia Forecasted Market Size by Type (2024-2029)
5 Nocturia Breakdown Data by Sale Channels
5.1 Global Nocturia Historic Market Size by Sale Channels (2018-2023)
5.2 Global Nocturia Forecasted Market Size by Sale Channels (2024-2029)
6 North America
6.1 North America Nocturia Market Size (2018-2029)
6.2 North America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Nocturia Market Size by Country (2018-2023)
6.4 North America Nocturia Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nocturia Market Size (2018-2029)
7.2 Europe Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Nocturia Market Size by Country (2018-2023)
7.4 Europe Nocturia Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nocturia Market Size (2018-2029)
8.2 Asia-Pacific Nocturia Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Nocturia Market Size by Region (2018-2023)
8.4 Asia-Pacific Nocturia Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nocturia Market Size (2018-2029)
9.2 Latin America Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Nocturia Market Size by Country (2018-2023)
9.4 Latin America Nocturia Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturia Market Size (2018-2029)
10.2 Middle East & Africa Nocturia Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Nocturia Market Size by Country (2018-2023)
10.4 Middle East & Africa Nocturia Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Nocturia Introduction
11.1.4 Astellas Pharma Revenue in Nocturia Business (2018-2023)
11.1.5 Astellas Pharma Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Nocturia Introduction
11.2.4 Allergan Revenue in Nocturia Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Detail
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2018-2023)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Detail
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Nocturia Introduction
11.4.4 Eli Lilly Revenue in Nocturia Business (2018-2023)
11.4.5 Eli Lilly Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Nocturia Introduction
11.5.4 GlaxoSmithKline Revenue in Nocturia Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Nocturia Introduction
11.6.4 Sanofi Revenue in Nocturia Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nocturia Introduction
11.7.4 Pfizer Revenue in Nocturia Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Nocturia Introduction
11.8.4 Abbott Revenue in Nocturia Business (2018-2023)
11.8.5 Abbott Recent Development
11.9 Teva
11.9.1 Teva Company Detail
11.9.2 Teva Business Overview
11.9.3 Teva Nocturia Introduction
11.9.4 Teva Revenue in Nocturia Business (2018-2023)
11.9.5 Teva Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Nocturia Introduction
11.10.4 Mylan Revenue in Nocturia Business (2018-2023)
11.10.5 Mylan Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Nocturia Introduction
11.11.4 Johnson & Johnson Revenue in Nocturia Business (2018-2023)
11.11.5 Johnson & Johnson Recent Development
11.12 Hainan Zhonghe Pharmaceutical
11.12.1 Hainan Zhonghe Pharmaceutical Company Detail
11.12.2 Hainan Zhonghe Pharmaceutical Business Overview
11.12.3 Hainan Zhonghe Pharmaceutical Nocturia Introduction
11.12.4 Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2018-2023)
11.12.5 Hainan Zhonghe Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Desmopressin
    Table 3. Key Players of Anticholinergic Drugs
    Table 4. Key Players of Alpha Blockers
    Table 5. Key Players of Diuretics
    Table 6. Key Players of Others
    Table 7. Global Nocturia Market Size Growth by Sale Channels (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Nocturia Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Nocturia Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Nocturia Market Share by Region (2018-2023)
    Table 11. Global Nocturia Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Nocturia Market Share by Region (2024-2029)
    Table 13. Nocturia Market Trends
    Table 14. Nocturia Market Drivers
    Table 15. Nocturia Market Challenges
    Table 16. Nocturia Market Restraints
    Table 17. Global Nocturia Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Nocturia Market Share by Players (2018-2023)
    Table 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2022)
    Table 20. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Nocturia Product Solution and Service
    Table 24. Date of Enter into Nocturia Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nocturia Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Nocturia Revenue Market Share by Type (2018-2023)
    Table 28. Global Nocturia Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Nocturia Revenue Market Share by Type (2024-2029)
    Table 30. Global Nocturia Market Size by Sale Channels (2018-2023) & (US$ Million)
    Table 31. Global Nocturia Revenue Market Share by Sale Channels (2018-2023)
    Table 32. Global Nocturia Forecasted Market Size by Sale Channels (2024-2029) & (US$ Million)
    Table 33. Global Nocturia Revenue Market Share by Sale Channels (2024-2029)
    Table 34. North America Nocturia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Nocturia Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Nocturia Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Nocturia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Nocturia Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Nocturia Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Nocturia Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Nocturia Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Nocturia Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Nocturia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Nocturia Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Nocturia Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Nocturia Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Nocturia Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Nocturia Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Astellas Pharma Company Detail
    Table 50. Astellas Pharma Business Overview
    Table 51. Astellas Pharma Nocturia Product
    Table 52. Astellas Pharma Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 53. Astellas Pharma Recent Development
    Table 54. Allergan Company Detail
    Table 55. Allergan Business Overview
    Table 56. Allergan Nocturia Product
    Table 57. Allergan Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 58. Allergan Recent Development
    Table 59. Ferring Pharmaceuticals Company Detail
    Table 60. Ferring Pharmaceuticals Business Overview
    Table 61. Ferring Pharmaceuticals Nocturia Product
    Table 62. Ferring Pharmaceuticals Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 63. Ferring Pharmaceuticals Recent Development
    Table 64. Eli Lilly Company Detail
    Table 65. Eli Lilly Business Overview
    Table 66. Eli Lilly Nocturia Product
    Table 67. Eli Lilly Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 68. Eli Lilly Recent Development
    Table 69. GlaxoSmithKline Company Detail
    Table 70. GlaxoSmithKline Business Overview
    Table 71. GlaxoSmithKline Nocturia Product
    Table 72. GlaxoSmithKline Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 73. GlaxoSmithKline Recent Development
    Table 74. Sanofi Company Detail
    Table 75. Sanofi Business Overview
    Table 76. Sanofi Nocturia Product
    Table 77. Sanofi Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 78. Sanofi Recent Development
    Table 79. Pfizer Company Detail
    Table 80. Pfizer Business Overview
    Table 81. Pfizer Nocturia Product
    Table 82. Pfizer Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 83. Pfizer Recent Development
    Table 84. Abbott Company Detail
    Table 85. Abbott Business Overview
    Table 86. Abbott Nocturia Product
    Table 87. Abbott Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 88. Abbott Recent Development
    Table 89. Teva Company Detail
    Table 90. Teva Business Overview
    Table 91. Teva Nocturia Product
    Table 92. Teva Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 93. Teva Recent Development
    Table 94. Mylan Company Detail
    Table 95. Mylan Business Overview
    Table 96. Mylan Nocturia Product
    Table 97. Mylan Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 98. Mylan Recent Development
    Table 99. Johnson & Johnson Company Detail
    Table 100. Johnson & Johnson Business Overview
    Table 101. Johnson & Johnson Nocturia Product
    Table 102. Johnson & Johnson Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 103. Johnson & Johnson Recent Development
    Table 104. Hainan Zhonghe Pharmaceutical Company Detail
    Table 105. Hainan Zhonghe Pharmaceutical Business Overview
    Table 106. Hainan Zhonghe Pharmaceutical Nocturia Product
    Table 107. Hainan Zhonghe Pharmaceutical Revenue in Nocturia Business (2018-2023) & (US$ Million)
    Table 108. Hainan Zhonghe Pharmaceutical Recent Development
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nocturia Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Nocturia Market Share by Type: 2022 VS 2029
    Figure 3. Desmopressin Features
    Figure 4. Anticholinergic Drugs Features
    Figure 5. Alpha Blockers Features
    Figure 6. Diuretics Features
    Figure 7. Others Features
    Figure 8. Global Nocturia Market Size Comparison by Sale Channels (2023-2029) & (US$ Million)
    Figure 9. Global Nocturia Market Share by Sale Channels: 2022 VS 2029
    Figure 10. Hospital Pharmacies Case Studies
    Figure 11. Retail Pharmacies Case Studies
    Figure 12. Online Pharmacies Case Studies
    Figure 13. Nocturia Report Years Considered
    Figure 14. Global Nocturia Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Nocturia Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Nocturia Market Share by Region: 2022 VS 2029
    Figure 17. Global Nocturia Market Share by Players in 2022
    Figure 18. Global Top Nocturia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nocturia as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2022
    Figure 20. North America Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Nocturia Market Share by Country (2018-2029)
    Figure 22. United States Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Nocturia Market Share by Country (2018-2029)
    Figure 26. Germany Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Nocturia Market Share by Region (2018-2029)
    Figure 34. China Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Nocturia Market Share by Country (2018-2029)
    Figure 42. Mexico Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Nocturia Market Share by Country (2018-2029)
    Figure 46. Turkey Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Nocturia Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Astellas Pharma Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 49. Allergan Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 50. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 51. Eli Lilly Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 52. GlaxoSmithKline Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 53. Sanofi Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 54. Pfizer Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 55. Abbott Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 56. Teva Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 57. Mylan Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 59. Hainan Zhonghe Pharmaceutical Revenue Growth Rate in Nocturia Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS